Safety and efficacy of tumor-infiltrating lymphocyte (TIL) therapy with reduced-dose lymphodepleting conditioning in high-risk metastatic melanoma patients
作者
Lilit Karapetyan,Joel Kuriakose,Elizabeth DiMaggio,Kimberly Ward,J. C. W. Chau,Christopher Otteni,Denise Kalos,Johannes Ali,MacLean Hall,Matthew Beatty,Olga Klinkova,Mohammed Alomar,Eric Gaskill,Rebecca Gonzalez,Hanna Bailey,Michael Yu,Nam Tran,Lianicet Rodriguez-Alfonso,Eliane Vieira,Karla E. Adams